Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransCode Therapeutics Inc.

0.3052
+0.032712.00%
Volume:12.95M
Turnover:4.34M
Market Cap:7.12M
PE:0.00
High:0.3850
Open:0.2784
Low:0.2784
Close:0.2725
Loading ...

Transcode Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
16 Apr

TransCode Therapeutics Delays Annual Report Filing

TIPRANKS
·
01 Apr

TransCode Therapeutics Starts Dosing for Experimental Cancer Treatment in Early Trial

MT Newswires Live
·
28 Mar

TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138

PR Newswire
·
28 Mar

BRIEF-Transcode Therapeutics, Inc. Announces Closing Of Registered Direct Offering

Reuters
·
26 Mar

Transcode Therapeutics, Inc. Announces Closing of Registered Direct Offering

THOMSON REUTERS
·
26 Mar

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires Live
·
25 Mar

Top Midday Decliners

MT Newswires Live
·
25 Mar

TransCode Therapeutics Starts $10 Million Direct Offering of Stock, Warrants

MT Newswires Live
·
24 Mar

Transcode Therapeutics Inc - to Sell 10.25 Mln Shares and Warrants at $0.98 Each

THOMSON REUTERS
·
24 Mar

Transcode Therapeutics, Inc. Announces Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
24 Mar

TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

PR Newswire
·
24 Mar

BUZZ-U.S. STOCKS ON THE MOVE-ACNB, Carnival Corp, Boeing

Reuters
·
21 Mar

Wall Street Set to Open Lower Friday as Investors Look to End Losing Week Streak

MT Newswires Live
·
21 Mar

Transcode Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

TransCode Therapeutics Says Safety Review Committee Approves Opening of Fourth Group in Phase 1 Trial to Treat Metastatic Cancers

MT Newswires Live
·
13 Mar

Transcode Therapeutics’ fourth cohort in Phase 1/2 cancer trial approved

TIPRANKS
·
13 Mar

TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial

PR Newswire
·
13 Mar

TransCode Therapeutics, Inc. Announces Results of Special Meeting

PR Newswire
·
26 Feb

Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast

Benzinga
·
26 Feb